GenScript Expands Its THE™ Elite Antibody Series

Piscataway, NJ, August 18, 2009 --(PR.com)-- Internationally recognized biology contract research organization, GenScript US Inc., has expanded its THE TM Elite antibody series by adding THE™ Anti-DYKDDDDK mAb.

The DYKDDDDK peptide is a small component of the epitope that does not interfere with the bioactivity or the biodistribution of the recombinant protein. This trait allows it to be used extensively as a general epitope tag in expression vectors. THE™ Anti-DYKDDDDK mAb is a high-affinity monoclonal antibody that can be used to detect DYKDDDDK-tagged proteins.

GenScript THE™ Elite antibody series contains two categories, THE™ Epitope Tag Antibody and THE™ Loading Controls. THE™ Epitope Tag Antibody includes THE™ Anti-c-Myc mAb, THE™ Anti-GST mAb, THE™ Anti-His mAb, THE™ Anti-HA mAb, and the newly added THE™ Anti-DYKDDDDK mAb. THE™ Loading Controls includes THE™ Anti-β-Actin mAb. The THE™ antibodies are picked by GenScript due to their exceptional performance and popularity. In the mean time, GenScript offers free trial samples for all members in the category of THE™ Epitope Tag Antibody.

GenScript is a contract research organization (CRO) specialized in biological research and drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. Headquartered in Piscataway, New Jersey, GenScript has become a world-leading Biology CRO and the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.

###